1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Engineered	_	_	VBN	_	_	_	_	_
2	proteins	_	_	NNS	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	tailored	_	_	VBN	_	_	_	_	_
5	properties	_	_	NNS	_	_	_	_	_
6	evolved	_	_	VBN	_	_	_	_	_
7	from	_	_	IN	_	_	_	_	_
8	natural	_	_	JJ	_	_	_	_	_
9	precursors	_	_	NNS	_	_	_	_	_
10	have	_	_	VBP	_	_	_	_	_
11	been	_	_	VBN	_	_	_	_	_
12	playing	_	_	VBG	_	_	_	_	_
13	an	_	_	DT	_	_	_	_	_
14	increasingly	_	_	RB	_	_	_	_	_
15	important	_	_	JJ	_	_	_	_	_
16	role	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	spectrum	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	agricultural	_	_	JJ	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	industrial	_	_	JJ	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	biomedical	_	_	JJ	_	_	_	_	_
27	applications	_	_	NNS	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	protein	_	_	NN	_	_	_	_	_
5	engineering	_	_	NN	_	_	_	_	_
6	holds	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	potential	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	transforming	_	_	VBG	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	metabolic	_	_	JJ	_	_	_	_	_
13	drug	_	_	NN	_	_	_	_	_
14	landscape	_	_	NN	_	_	_	_	_
15	through	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	development	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	smart	_	_	JJ	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	stimulus-responsive	_	_	JJ	_	_	_	_	_
22	drug	_	_	NN	_	_	_	_	_
23	systems	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	industrial	_	_	JJ	_	_	_	_	_
3	processes	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	protein	_	_	NN	_	_	_	_	_
6	engineering	_	_	NN	_	_	_	_	_
7	enables	_	_	VBZ	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	production	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	enzymes	_	_	NNS	_	_	_	_	_
12	that	_	_	WDT	_	_	_	_	_
13	offer	_	_	VBP	_	_	_	_	_
14	unique	_	_	JJ	_	_	_	_	_
15	advantages	_	_	NNS	_	_	_	_	_
16	compared	_	_	VBN	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	chemical	_	_	JJ	_	_	_	_	_
19	catalysts	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	such	_	_	JJ	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	biodegradability	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	stereoselectivity	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	substrate	_	_	NN	_	_	_	_	_
28	specificity	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	functionality	_	_	NN	_	_	_	_	_
31	under	_	_	IN	_	_	_	_	_
32	relatively	_	_	RB	_	_	_	_	_
33	mild	_	_	JJ	_	_	_	_	_
34	solvents	_	_	NNS	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	temperatures	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	pHs	_	_	NN	_	_	_	_	_
39	and	_	_	CC	_	_	_	_	_
40	pressures	_	_	NNS	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	and	_	_	CC	_	_	_	_	_
43	stability	_	_	NN	_	_	_	_	_
44	at	_	_	IN	_	_	_	_	_
45	extreme	_	_	JJ	_	_	_	_	_
46	conditions	_	_	NNS	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Today	_	_	NN	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	protein	_	_	NN	_	_	_	_	_
4	engineering	_	_	NN	_	_	_	_	_
5	also	_	_	RB	_	_	_	_	_
6	plays	_	_	VBZ	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	critical	_	_	JJ	_	_	_	_	_
9	role	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	advancing	_	_	VBG	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	emerging	_	_	VBG	_	_	_	_	_
14	field	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	synthetic	_	_	JJ	_	_	_	_	_
17	biology	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	including	_	_	VBG	_	_	_	_	_
20	optimizing	_	_	VBG	_	_	_	_	_
21	pathway	_	_	NN	_	_	_	_	_
22	enzymes	_	_	NNS	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	regulatory	_	_	JJ	_	_	_	_	_
25	elements	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	balancing	_	_	VBG	_	_	_	_	_
28	pathway	_	_	NN	_	_	_	_	_
29	redox	_	_	NN	_	_	_	_	_
30	equivalents	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	as	_	_	RB	_	_	_	_	_
33	well	_	_	RB	_	_	_	_	_
34	as	_	_	IN	_	_	_	_	_
35	tuning	_	_	VBG	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	expression	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	pathway	_	_	NN	_	_	_	_	_
40	genes	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	two	_	_	CD	_	_	_	_	_
4	main	_	_	JJ	_	_	_	_	_
5	strategies	_	_	NNS	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	protein	_	_	NN	_	_	_	_	_
8	engineering	_	_	NN	_	_	_	_	_
9	:	_	_	:	_	_	_	_	_
10	rational	_	_	JJ	_	_	_	_	_
11	design	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	directed	_	_	VBN	_	_	_	_	_
14	evolution	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Rational	_	_	JJ	_	_	_	_	_
2	design	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	which	_	_	WDT	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	mostly	_	_	RB	_	_	_	_	_
7	carried	_	_	VBN	_	_	_	_	_
8	out	_	_	RP	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	silico	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	knowledge-based	_	_	JJ	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	deterministic	_	_	JJ	_	_	_	_	_
16	engineering	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	proteins	_	_	NNS	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	needs	_	_	VBZ	_	_	_	_	_
5	prior	_	_	JJ	_	_	_	_	_
6	information	_	_	NN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	target	_	_	NN	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	such	_	_	JJ	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	structural	_	_	JJ	_	_	_	_	_
15	model	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	sequence	_	_	NN	_	_	_	_	_
18	relationship	_	_	NN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	homologs	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	insights	_	_	NNS	_	_	_	_	_
24	into	_	_	IN	_	_	_	_	_
25	its	_	_	PRP$	_	_	_	_	_
26	biophysical	_	_	JJ	_	_	_	_	_
27	function	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	powerful	_	_	JJ	_	_	_	_	_
4	approach	_	_	NN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	test	_	_	VB	_	_	_	_	_
7	general	_	_	JJ	_	_	_	_	_
8	theories	_	_	NNS	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	chemistry	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	rational	_	_	JJ	_	_	_	_	_
14	design	_	_	NN	_	_	_	_	_
15	can	_	_	MD	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	achieved	_	_	VBN	_	_	_	_	_
18	either	_	_	CC	_	_	_	_	_
19	by	_	_	IN	_	_	_	_	_
20	single-point	_	_	JJ	_	_	_	_	_
21	mutation	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	exchange	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	elements	_	_	NNS	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	secondary	_	_	JJ	_	_	_	_	_
28	structure	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	exchange	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	whole	_	_	JJ	_	_	_	_	_
33	domains	_	_	NNS	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	or	_	_	CC	_	_	_	_	_
36	by	_	_	IN	_	_	_	_	_
37	fusion	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	enzymes	_	_	NNS	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Novel	_	_	JJ	_	_	_	_	_
2	computational	_	_	JJ	_	_	_	_	_
3	tools	_	_	NNS	_	_	_	_	_
4	have	_	_	VBP	_	_	_	_	_
5	constantly	_	_	RB	_	_	_	_	_
6	improved	_	_	VBN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	resulting	_	_	VBG	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	dramatic	_	_	JJ	_	_	_	_	_
11	increase	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	sizes	_	_	NNS	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	mutant	_	_	JJ	_	_	_	_	_
17	libraries	_	_	NNS	_	_	_	_	_
18	that	_	_	WDT	_	_	_	_	_
19	can	_	_	MD	_	_	_	_	_
20	be	_	_	VB	_	_	_	_	_
21	designed	_	_	VBN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Genome-scale	_	_	JJ	_	_	_	_	_
2	metabolic	_	_	JJ	_	_	_	_	_
3	models	_	_	NNS	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	GEMs	_	_	NNS	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	informed	_	_	VBN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	expanded	_	_	VBN	_	_	_	_	_
11	variant	_	_	NN	_	_	_	_	_
12	design	_	_	NN	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	many	_	_	JJ	_	_	_	_	_
15	industrially	_	_	RB	_	_	_	_	_
16	relevant	_	_	JJ	_	_	_	_	_
17	microorganisms	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	multiplex	_	_	NN	_	_	_	_	_
4	automated	_	_	JJ	_	_	_	_	_
5	genome	_	_	NN	_	_	_	_	_
6	evolution	_	_	NN	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	MAGE	_	_	NN	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	CRISPR/Cas	_	_	NNP	_	_	_	_	_
12	systems	_	_	NNS	_	_	_	_	_
13	have	_	_	VBP	_	_	_	_	_
14	significantly	_	_	RB	_	_	_	_	_
15	improved	_	_	VBN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	throughput	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	genome	_	_	NN	_	_	_	_	_
20	editing	_	_	NN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	precision	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	reduced	_	_	VBN	_	_	_	_	_
25	cost	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	time	_	_	NN	_	_	_	_	_
28	required	_	_	VBN	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	explore	_	_	VB	_	_	_	_	_
31	many	_	_	JJ	_	_	_	_	_
32	protein	_	_	NN	_	_	_	_	_
33	targets	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	MAGE	_	_	NN	_	_	_	_	_
5	enables	_	_	VBZ	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	rapid	_	_	JJ	_	_	_	_	_
8	generation	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	billions	_	_	NNS	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	mutants	_	_	NNS	_	_	_	_	_
13	by	_	_	IN	_	_	_	_	_
14	repeated	_	_	VBN	_	_	_	_	_
15	insertion	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	deletion	_	_	NN	_	_	_	_	_
18	or	_	_	CC	_	_	_	_	_
19	mutation	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	DNA	_	_	NN	_	_	_	_	_
22	at	_	_	IN	_	_	_	_	_
23	multiple	_	_	JJ	_	_	_	_	_
24	chromosomal	_	_	JJ	_	_	_	_	_
25	targets	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Overall	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	unprecedented	_	_	JJ	_	_	_	_	_
5	capability	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	designing	_	_	VBG	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	building	_	_	VBG	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	large	_	_	JJ	_	_	_	_	_
12	number	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	variants	_	_	NNS	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	rational	_	_	JJ	_	_	_	_	_
17	protein	_	_	NN	_	_	_	_	_
18	design	_	_	NN	_	_	_	_	_
19	has	_	_	VBZ	_	_	_	_	_
20	placed	_	_	VBN	_	_	_	_	_
21	increased	_	_	VBN	_	_	_	_	_
22	demands	_	_	NNS	_	_	_	_	_
23	on	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	throughput	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	screening	_	_	NN	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	selection	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Directed	_	_	VBN	_	_	_	_	_
2	evolution	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	on	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	other	_	_	JJ	_	_	_	_	_
7	hand	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	mimics	_	_	VBZ	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	process	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	natural	_	_	JJ	_	_	_	_	_
14	selection	_	_	NN	_	_	_	_	_
15	through	_	_	IN	_	_	_	_	_
16	random	_	_	JJ	_	_	_	_	_
17	mutagenesis	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	steer	_	_	VB	_	_	_	_	_
20	proteins	_	_	NNS	_	_	_	_	_
21	or	_	_	CC	_	_	_	_	_
22	nucleic	_	_	JJ	_	_	_	_	_
23	acids	_	_	NNS	_	_	_	_	_
24	toward	_	_	IN	_	_	_	_	_
25	desired	_	_	VBN	_	_	_	_	_
26	traits	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Unlike	_	_	IN	_	_	_	_	_
2	rational	_	_	JJ	_	_	_	_	_
3	protein	_	_	NN	_	_	_	_	_
4	design	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	directed	_	_	VBN	_	_	_	_	_
7	evolution	_	_	NN	_	_	_	_	_
8	requires	_	_	VBZ	_	_	_	_	_
9	neither	_	_	DT	_	_	_	_	_
10	prior	_	_	JJ	_	_	_	_	_
11	knowledge	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	protein	_	_	NN	_	_	_	_	_
15	’s	_	_	POS	_	_	_	_	_
16	detailed	_	_	JJ	_	_	_	_	_
17	structure	_	_	NN	_	_	_	_	_
18	nor	_	_	CC	_	_	_	_	_
19	prediction	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	effects	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	various	_	_	JJ	_	_	_	_	_
25	mutations	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	directed	_	_	VBN	_	_	_	_	_
4	evolution	_	_	NN	_	_	_	_	_
5	makes	_	_	VBZ	_	_	_	_	_
6	it	_	_	PRP	_	_	_	_	_
7	possible	_	_	JJ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	identify	_	_	VB	_	_	_	_	_
10	undiscovered	_	_	JJ	_	_	_	_	_
11	protein	_	_	NN	_	_	_	_	_
12	sequences	_	_	NNS	_	_	_	_	_
13	which	_	_	WDT	_	_	_	_	_
14	have	_	_	VBP	_	_	_	_	_
15	novel	_	_	JJ	_	_	_	_	_
16	functions	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	synthetic	_	_	JJ	_	_	_	_	_
4	biologists	_	_	NNS	_	_	_	_	_
5	also	_	_	RB	_	_	_	_	_
6	increasingly	_	_	RB	_	_	_	_	_
7	rely	_	_	VBP	_	_	_	_	_
8	on	_	_	IN	_	_	_	_	_
9	directed	_	_	VBN	_	_	_	_	_
10	evolution	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	optimize	_	_	VB	_	_	_	_	_
13	engineered	_	_	VBN	_	_	_	_	_
14	biological	_	_	JJ	_	_	_	_	_
15	systems	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	directed	_	_	VBN	_	_	_	_	_
5	evolution	_	_	NN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	truly	_	_	RB	_	_	_	_	_
9	effective	_	_	JJ	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	very	_	_	RB	_	_	_	_	_
12	large	_	_	JJ	_	_	_	_	_
13	libraries	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	mutants	_	_	NNS	_	_	_	_	_
16	must	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	screened	_	_	VBN	_	_	_	_	_
19	under	_	_	IN	_	_	_	_	_
20	conditions	_	_	NNS	_	_	_	_	_
21	that	_	_	WDT	_	_	_	_	_
22	closely	_	_	RB	_	_	_	_	_
23	match	_	_	VBP	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	desired	_	_	VBN	_	_	_	_	_
26	functionality	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	throughput	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	screening	_	_	NN	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	variants	_	_	NNS	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	improved	_	_	VBN	_	_	_	_	_
11	traits	_	_	NNS	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	major	_	_	JJ	_	_	_	_	_
15	factor	_	_	NN	_	_	_	_	_
16	dictating	_	_	VBG	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	efficiency	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	directed	_	_	VBN	_	_	_	_	_
21	evolution	_	_	NN	_	_	_	_	_
22	given	_	_	VBN	_	_	_	_	_
23	that	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	libraries	_	_	NNS	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	random	_	_	JJ	_	_	_	_	_
28	mutants	_	_	NNS	_	_	_	_	_
29	can	_	_	MD	_	_	_	_	_
30	be	_	_	VB	_	_	_	_	_
31	easily	_	_	RB	_	_	_	_	_
32	on	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	scale	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	108	_	_	CD	_	_	_	_	_
37	–	_	_	TO	_	_	_	_	_
38	109	_	_	CD	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Proteins	_	_	NNS	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	engineered	_	_	VBN	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	properties	_	_	NNS	_	_	_	_	_
6	such	_	_	JJ	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	affinity	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	selectivity	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	stability	_	_	NN	_	_	_	_	_
13	or	_	_	CC	_	_	_	_	_
14	enzymatic	_	_	JJ	_	_	_	_	_
15	activity	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Often	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	when	_	_	WRB	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	cell	_	_	NN	_	_	_	_	_
6	based	_	_	VBN	_	_	_	_	_
7	fluorescent	_	_	JJ	_	_	_	_	_
8	readout	_	_	NN	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	achievable	_	_	JJ	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	screening	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	engineered	_	_	VBN	_	_	_	_	_
15	protein	_	_	NN	_	_	_	_	_
16	libraries	_	_	NNS	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	performed	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	fluorescence-activated	_	_	JJ	_	_	_	_	_
21	cell	_	_	NN	_	_	_	_	_
22	sorting	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	FACS	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	separate	_	_	VB	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	population	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	cells	_	_	NNS	_	_	_	_	_
32	into	_	_	IN	_	_	_	_	_
33	sub-populations	_	_	NNS	_	_	_	_	_
34	based	_	_	VBN	_	_	_	_	_
35	on	_	_	IN	_	_	_	_	_
36	fluorescent	_	_	JJ	_	_	_	_	_
37	labeling	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	case	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	phenotype-genotype	_	_	JJ	_	_	_	_	_
7	connection	_	_	NN	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	unbroken	_	_	JJ	_	_	_	_	_
10	because	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	cells	_	_	NNS	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	selected	_	_	VBN	_	_	_	_	_
15	directly	_	_	RB	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	Lipovšek	_	_	NNP	_	_	_	_	_
5	et	_	_	FW	_	_	_	_	_
6	al.	_	_	FW	_	_	_	_	_
7	reported	_	_	VBD	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	vitro	_	_	FW	_	_	_	_	_
10	selection	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	catalytically	_	_	RB	_	_	_	_	_
13	active	_	_	JJ	_	_	_	_	_
14	enzymes	_	_	NNS	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	horseradish	_	_	NN	_	_	_	_	_
17	peroxidase	_	_	NN	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	large	_	_	JJ	_	_	_	_	_
21	libraries	_	_	NNS	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	variants	_	_	NNS	_	_	_	_	_
24	displayed	_	_	VBN	_	_	_	_	_
25	on	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	surface	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	yeast	_	_	NN	_	_	_	_	_
31	S.	_	_	NN	_	_	_	_	_
32	cerevisiae	_	_	NN	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	separated	_	_	VBN	_	_	_	_	_
35	by	_	_	IN	_	_	_	_	_
36	FACS	_	_	NNP	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	improve	_	_	VB	_	_	_	_	_
3	substrate	_	_	NN	_	_	_	_	_
4	specificity	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	glycosyltransferases	_	_	NNS	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	directed	_	_	VBN	_	_	_	_	_
9	evolution	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	Aharoni	_	_	NNP	_	_	_	_	_
12	et	_	_	FW	_	_	_	_	_
13	al.	_	_	FW	_	_	_	_	_
14	screened	_	_	VBD	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	library	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	over	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	million	_	_	CD	_	_	_	_	_
21	sialyltransferases	_	_	NNS	_	_	_	_	_
22	mutants	_	_	NNS	_	_	_	_	_
23	using	_	_	VBG	_	_	_	_	_
24	FACS	_	_	NNP	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	found	_	_	VBD	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	variant	_	_	NN	_	_	_	_	_
29	with	_	_	IN	_	_	_	_	_
30	up	_	_	IN	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	400-fold	_	_	CD	_	_	_	_	_
33	higher	_	_	JJR	_	_	_	_	_
34	catalytic	_	_	JJ	_	_	_	_	_
35	efficiency	_	_	NN	_	_	_	_	_
36	for	_	_	IN	_	_	_	_	_
37	transfer	_	_	NN	_	_	_	_	_
38	to	_	_	TO	_	_	_	_	_
39	a	_	_	DT	_	_	_	_	_
40	variety	_	_	NN	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	fluorescently	_	_	RB	_	_	_	_	_
43	labeled	_	_	VBN	_	_	_	_	_
44	acceptor	_	_	NN	_	_	_	_	_
45	sugars	_	_	NNS	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	their	_	_	PRP$	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	formation	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	sialosides	_	_	NNS	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	intact	_	_	JJ	_	_	_	_	_
11	E.	_	_	NN	_	_	_	_	_
12	coli	_	_	NN	_	_	_	_	_
13	cells	_	_	NNS	_	_	_	_	_
14	was	_	_	VBD	_	_	_	_	_
15	detected	_	_	VBN	_	_	_	_	_
16	by	_	_	IN	_	_	_	_	_
17	selectively	_	_	RB	_	_	_	_	_
18	trapping	_	_	VBG	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	fluorescently	_	_	RB	_	_	_	_	_
21	labeled	_	_	VBN	_	_	_	_	_
22	transfer	_	_	NN	_	_	_	_	_
23	products	_	_	NNS	_	_	_	_	_
24	within	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	cell	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	resulting	_	_	VBG	_	_	_	_	_
30	cell	_	_	NN	_	_	_	_	_
31	population	_	_	NN	_	_	_	_	_
32	was	_	_	VBD	_	_	_	_	_
33	analyzed	_	_	VBN	_	_	_	_	_
34	and	_	_	CC	_	_	_	_	_
35	sorted	_	_	VBN	_	_	_	_	_
36	using	_	_	VBG	_	_	_	_	_
37	FACS	_	_	NNPS	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	many	_	_	JJ	_	_	_	_	_
4	desirable	_	_	JJ	_	_	_	_	_
5	properties	_	_	NNS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	not	_	_	RB	_	_	_	_	_
8	amenable	_	_	JJ	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	direct	_	_	JJ	_	_	_	_	_
11	interrogation	_	_	NN	_	_	_	_	_
12	via	_	_	IN	_	_	_	_	_
13	FACS	_	_	NNP	_	_	_	_	_
14	because	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	phenotype	_	_	NN	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	not	_	_	RB	_	_	_	_	_
19	inherent	_	_	JJ	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	a	_	_	DT	_	_	_	_	_
22	single	_	_	JJ	_	_	_	_	_
23	cell	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	example	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	when	_	_	WRB	_	_	_	_	_
29	improving	_	_	VBG	_	_	_	_	_
30	a	_	_	DT	_	_	_	_	_
31	protein	_	_	NN	_	_	_	_	_
32	excreted	_	_	VBN	_	_	_	_	_
33	into	_	_	IN	_	_	_	_	_
34	growth	_	_	NN	_	_	_	_	_
35	medium	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Properties	_	_	NNS	_	_	_	_	_
2	such	_	_	JJ	_	_	_	_	_
3	as	_	_	IN	_	_	_	_	_
4	extracellular	_	_	JJ	_	_	_	_	_
5	analyte	_	_	NN	_	_	_	_	_
6	consumption	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	product	_	_	NN	_	_	_	_	_
9	secretion	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	cell-cell	_	_	NN	_	_	_	_	_
12	interactions	_	_	NNS	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	not	_	_	RB	_	_	_	_	_
15	readily	_	_	RB	_	_	_	_	_
16	detectable	_	_	JJ	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	flow	_	_	NN	_	_	_	_	_
19	cytometry	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_
21	Screening	_	_	VBG	_	_	_	_	_
22	for	_	_	IN	_	_	_	_	_
23	‘	_	_	``	_	_	_	_	_
24	non-cellular	_	_	JJ	_	_	_	_	_
25	’	_	_	''	_	_	_	_	_
26	phenotypes	_	_	NNS	_	_	_	_	_
27	necessitates	_	_	VBZ	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	compartmentalization	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	single	_	_	JJ	_	_	_	_	_
32	cells	_	_	NNS	_	_	_	_	_
33	or	_	_	CC	_	_	_	_	_
34	an	_	_	DT	_	_	_	_	_
35	alternative	_	_	JJ	_	_	_	_	_
36	expression	_	_	NN	_	_	_	_	_
37	system	_	_	NN	_	_	_	_	_
38	to	_	_	TO	_	_	_	_	_
39	maintain	_	_	VB	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	linkage	_	_	NN	_	_	_	_	_
42	between	_	_	IN	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	phenotype	_	_	NN	_	_	_	_	_
45	that	_	_	WDT	_	_	_	_	_
46	the	_	_	DT	_	_	_	_	_
47	selection	_	_	NN	_	_	_	_	_
48	acts	_	_	VBZ	_	_	_	_	_
49	on	_	_	IN	_	_	_	_	_
50	and	_	_	CC	_	_	_	_	_
51	the	_	_	DT	_	_	_	_	_
52	genotype	_	_	NN	_	_	_	_	_
53	in	_	_	IN	_	_	_	_	_
54	which	_	_	WDT	_	_	_	_	_
55	the	_	_	DT	_	_	_	_	_
56	evolutionary	_	_	JJ	_	_	_	_	_
57	information	_	_	NN	_	_	_	_	_
58	is	_	_	VBZ	_	_	_	_	_
59	encoded	_	_	VBN	_	_	_	_	_
60	.	_	_	.	_	_	_	_	_


1	Compartmentalization	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	assays	_	_	NNS	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	arrays	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	wells	_	_	NNS	_	_	_	_	_
8	makes	_	_	VBZ	_	_	_	_	_
9	microtiter	_	_	NN	_	_	_	_	_
10	plates	_	_	NNS	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	far	_	_	RB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	most	_	_	RBS	_	_	_	_	_
15	widely	_	_	RB	_	_	_	_	_
16	used	_	_	VBN	_	_	_	_	_
17	screening	_	_	NN	_	_	_	_	_
18	platform	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	microplate-based	_	_	JJ	_	_	_	_	_
5	method	_	_	NN	_	_	_	_	_
6	becomes	_	_	VBZ	_	_	_	_	_
7	problematic	_	_	JJ	_	_	_	_	_
8	when	_	_	WRB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	assay	_	_	NN	_	_	_	_	_
11	volume	_	_	NN	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	less	_	_	JJR	_	_	_	_	_
14	than	_	_	IN	_	_	_	_	_
15	1	_	_	CD	_	_	_	_	_
16	µL	_	_	NN	_	_	_	_	_
17	due	_	_	JJ	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	evaporation	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	capillary	_	_	NN	_	_	_	_	_
22	forces	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Even	_	_	RB	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	robotic	_	_	JJ	_	_	_	_	_
4	automation	_	_	NN	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	liquid	_	_	NN	_	_	_	_	_
7	handling	_	_	VBG	_	_	_	_	_
8	using	_	_	VBG	_	_	_	_	_
9	1536-well	_	_	JJ	_	_	_	_	_
10	plates	_	_	NNS	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	assuming	_	_	VBG	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	processing	_	_	NN	_	_	_	_	_
15	rate	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	1	_	_	CD	_	_	_	_	_
18	plate	_	_	NN	_	_	_	_	_
19	per	_	_	IN	_	_	_	_	_
20	minute	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	throughput	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	well	_	_	RB	_	_	_	_	_
27	based	_	_	VBN	_	_	_	_	_
28	assay	_	_	NN	_	_	_	_	_
29	is	_	_	VBZ	_	_	_	_	_
30	approximately	_	_	RB	_	_	_	_	_
31	25	_	_	CD	_	_	_	_	_
32	samples/sec	_	_	NN	_	_	_	_	_
33	for	_	_	IN	_	_	_	_	_
34	a	_	_	DT	_	_	_	_	_
35	prompt	_	_	JJ	_	_	_	_	_
36	optical	_	_	JJ	_	_	_	_	_
37	measurement	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_

